Ahmedabad-based Lincoln Pharmaceuticals Ltd (LPL) said it will invest Rs50 crore to set up a plant which would be in accordance to US Food & Drug Administration (FDA) guidelines.
It has planned to achieve the top line of Rs200 crore with a bottom line Rs20 crore year with earning per share (EPS) of Rs17 a share for the current financial year, LPL said in a regulatory filing.
LPL said it is strengthening its international business by way of setting up FDA plant for oral formulation for regulatory markets like US, UK, Europe, Brazil and South Africa.
On Tuesday, Lincoln Pharma shares jumped 11.9% to Rs38 on the BSE, while the Sensex ended at 0.3% down at 17,878 points.
Mahindra Satyam Ltd, the new brand identity of Satyam Computer Services Ltd, said it appointed Roger Van Lier, as its business development executive in the Benelux. He will be responsible for driving customer relationships in the manufacturing sector, it said in a regulatory filing.
On Tuesday, Mahindra Satyam shares ended 1% down at Rs88 on the Bombay Stock Exchange, while the Sensex ended at 0.3% down at 17,878 points.